Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
申请人:Guyaux Michel
公开号:US20050020660A1
公开(公告)日:2005-01-27
The invention concerns quinuclidine derivatives of formula I or II wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention_show high affinities for m3 and/or m2 muscarinic receptors and are particularly suited for treating urinary incontinence.
本发明涉及式I或II的季铵盐衍生物,其中取代基如规范中所定义,以及它们作为药物的用途。本发明的化合物具有高亲和力m3和/或m2胆碱能受体,特别适用于治疗尿失禁。